Abstract
The cloning and characterization of the common fragile site (CFS) FRA6E (6q26) identified Parkin, the gene involved in the pathogenesis of many cases of juvenile, early-onset and, rarely, late-onset Parkinson's disease, as the third large gene to be localized within a large CFS. Initial analyses of Parkin indicated that in addition to playing a role in Parkinson's disease, it might also be involved in the development and/or progression of ovarian cancer. These analyses also indicated striking similarities among the large CFS-locus genes: fragile histidine triad gene (FHIT; 3p14.2), WW domain-containing oxidoreductase gene (WWOX; 16q23), and Parkin (6q26). Analyses of FHIT and WWOX in a variety of different cancer types have identified the presence of alternative transcripts with whole exon deletions. Interestingly, various whole exon duplications and deletions have been identified for Parkin in juvenile and early-onset Parkinson's patients. Therefore, we performed mutational/exon rearrangement analysis of Parkin in ovarian cancer cell lines and primary tumors. Four (66.7%) cell lines and four (18.2%) primary tumors were identified as being heterozygous for the duplication or deletion of a Parkin exon. Additionally, three of 23 (13.0%) nonovarian tumor-derived cell lines were also identified as having a duplication or deletion of one or more Parkin exons. Analysis of Parkin protein expression with antibodies revealed that most of the ovarian cancer cell lines and primary tumors had diminished or absent Parkin expression. While functional analyses have not yet been performed for Parkin, these data suggest that like FHIT and WWOX, Parkin may represent a tumor suppressor gene.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Arlt MF, Miller DE, Beer DG and Glover TW . (2002). Genes Chromosomes Cancer, 33, 82–92.
Becker NA, Thorland EC, Denison SR, Phillips LA and Smith DI . (2002). Oncogene, 21, 8713–8722.
Bednarek A ., Keck-Waggoner CL, Daniel RL, Laflin KJ, Bergsagel PL, Kiguchi K, Brenner AJ and Aldaz CM . (2001). Cancer Res., 61, 8068–8073.
Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA and Aldaz CM . (2000). Cancer Res., 60, 2140–2145.
Cesari R, Martin ES, Calin GA, Pentimalli F, Bichi R, McAdams H, Trapasso F, Drusco A, Shimizu M, Masciullo V, D'Andrilli G, Scambia, Picchio MC, Alder H, Godwin AK and Croce CM . (2003). Proc. Natl. Acad. Sci. USA, 100, 5956–5961.
Corbin S, Neilly ME, Espinosa R, Davis EM, McKeithan TW and LeBeau MM . (2002). Cancer Res., 62, 3477–3484.
Darios F, Corti O, Lücking CB, Hampe C, Muriel MP, Abbas N and Gu WJ . (2003). Hum. Mol. Genet., 12, 517–526.
Denison SR, Callahan G, Becker NA, Phillips LA and Smith DI . (2003). Genes Chromosomes Cancer, 38, 40–52.
Druck T, Berk L and Huebner K . (1998). Oncol. Res., 10, 341–345.
Druck T, Hadaczek P, Fu TB, Ohta M, Siprashvili Z, Baffa R, Negrini M, Kastury K, Veronese ML, Rosen D, Rothstein J, McCue P, Cotticelli MG, Inoue H, Croce CM and Huebner K . (1997). Cancer Res., 57, 504–512.
Feany MB and Pallanck LJ . (2003). Neuron, 38, 13–16.
Gamma A, Hagiwara K, Ke Y, Burke LM, Khan MA, Nahashima M, Bennett WP and Harris CC . (1997). Cancer Res., 57, 1435–1437.
Hattori N, Kitada T, Matsumine H, Asakawa S, Yamamura Y, Yoshino H, Kobayashi T, Yokochi M, Wang M, Yoritaka A, Konda T, Kuzuhara S, Naamura S, Shimizu M and Mizuno Y . (1998). Ann. Neurol., 4, 935–941.
Hedrich K, Kann M, Lanthaler AJ, Dalski A, Eskelson C, Landt O, Schwinger E, Vieregge P, Lang AE, Breakefiend XO, Ozelius LJ, Pramstaller PP and Klein C . (2001). Hum. Mol. Genet., 10, 1649–1656.
Hedrich K, Marder K, Harris J, Kann M, Lynch T, Meijia-Santana H, Pramstaller PP, Schwinger E, Bressman SB, Fahn S and Klein C . (2002). Neurology, 58, 1239–1246.
Hellman A, Zlotorynski E, Scherer SW, Cheung J, Vincent JB, Smith DI, Trakhtenbrot L and Kerem B . (2002). Cancer Cell, 1, 89–97.
Hoenicka J, Vidal L, Morales B, Ampuero I, Jimenez-Jimenez FJ, Berciano J, del Ser T, Jimenez Z, Ruiz PG and de Yebenes JG . (2002). Arch. Neurol., 59, 966–970.
Horowitz JM, Vernace VV, Myers J, Stachowiak MK, Hanlon DW, Fraley GS and Torres G . (2001). J. Chem. Neuroanat., 21, 75–93.
Huebner K, Garrison PN, Barnes LD and Croce CM . (1998). Ann. Rev. Genet., 32, 7–31.
Huynh DP, Scoles DR, Ho TH, Del Bigio MR and Pulst SM . (2000). Ann. Neurol., 48, 737–744.
Imai Y, Soda M and Takahashi R . (2000). J. Biol. Chem., 275, 35661–35664.
Ishii H, Damon KR, Vecchione A, Gong LY, Baffa R, Huebner K and Croce CM . (2001). JAMA, 286, 2441–2449.
Kahns S, Lykkebo S, Jakobsen LD, Nielson MS and Jensen PH . (2002). J. Biol. Chem., 8, 15303–15308.
Kann M, Jacobs H, Mohrmann K, Schumacher K, Hedrich K, Garrels J, Wiegers K, Schwinger E, Pramstaller PP, Breakefield XO, Ozelius LJ, Vieregge P and Klein C . (2002). Ann. Neurol., 51, 621–625.
Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizumo Y and Shimizu N . (1998). Nature, 392, 605–608.
Knudson AG . (2001). Nat. Rev. Cancer, 1, 157–162.
Krummel KA, Denison SR, Calhoun E, Phillips LA and Smith DI . (2002). Genes Chromosomes Cancer, 34, 154–167.
Krummel KA, Roberts LR, Kawakami M, Glover TW and Smith DI . (2000). Genomics, 69, 37–46.
Le Beau MM, Drabkin H, Glover TW, Gemmill R, Rassool FV, McKeithan TW and Smith DI . (1998). Genes Chromosomes Cancer, 21, 281–289.
Lücking CB, Durr A, Bonifati V, Vaughan J, De Michele G, Gasser T, Harhangi BS, Meco G, Denefle P, Wood NW, Agid Y and Brice A . (2000). N. Engl. J. Med., 342, 1560–1567.
Mangelsdorf M, Ried K, Woollatt E, Dayan S, Eyre H, Finnis M, Hobson L, Nancarrow J, Venter D, Baker E and Richards RI . (2000). Cancer Res., 60, 1683–1689.
Nichols WC, Pankratz N, Uniacke SK, Pauciulo MW, Halter C, Rudolph A, Conneally PM and Foroud T . (2002). J. Med. Genet., 39, 489–492.
Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM and Huebner K . (1996). Cell, 84, 587–597.
Paige AJ, Taylor KJ, Stewart A, Sgouros JG, Gabra H, Sellar GC, Smyth JF, Porteous DJ and Watson JE . (2000). Cancer Res., 60, 1690–1697.
Petrucelli L, O'Farrell C, Lockhart PJ, Baptista M, Kehoe K, Vink L, Choi P, Wolozin B, Farrer M, Hardy J and Cookson MR . (2002). Neuron, 36, 1007–1019.
Roz L, Gramegna M, Ishii H, Croce CM and Sozzi G . (2002). Proc. Natl. Acad. Sci. USA, 99, 3615–3620.
Shiraishi T, Druck T, Mimori K, Flomenberg J, Berk L, Alder H, Miller W, Huebner K and Croce CM . (2001). Proc. Natl. Acad. Sci. USA, 98, 5722–5727.
Siprashvili Z, Sozzi G, Barnes LD, McCue P, Robinson AK, Eryomin V, Sard L, Tagliabue E, Greco A, Fusetti L, Schwartz G, Pierotti MA, Croce CM and Huebner K . (1997). Proc. Natl. Acad. Sci. USA, 94, 13771–13776.
Smith DI, Huang H and Wang L . (1998). Int. J. Oncol., 12, 187–196.
Staropoli JF, McDermott C, Marinat C, Schulman B, Demireva E and Abeliovich A . (2003). Neuron, 37, 735–749.
Sutherland GR, Baker E and Richards RI . (1998). Trends Genet., 14, 501–506.
Tanaka K, Suzuki T, Chiba T, Shimura H, Hattori N and Mizuno Y . (2001). J. Mol. Med., 79, 482–494.
Verma R and Babu A (eds). (1995). Human Chromosomes: Principles and Techniques, 2nd edn. McGraw-Hill: New York.
West A, Periquet M, Lincoln S, Lucking CB, Nicholl D, Bonifati V, Rawal N, Gasser T, Lohmann E, Deleuze JF, Maraganore D, Levey A, Wood N, Durr A, Hardy J, Brice A and Farrer M . (2002). Am. J. Med. Genet., 114, 584–591.
Zhang Y, Gao J, Chung KK, Huang H, Dawson VL and Dawson TM . (2000). Proc. Natl. Acad. Sci. USA, 97, 13354–13359.
Acknowledgements
This work was supported by NIH Grant CA48031, Department of Defense Grant DAMD 17-99-1-9504, by the Minnesota Ovarian Cancer Alliance (MOCA) (all to DIS), and by the Deutsche Forschungsgemeinschaft Kl-1134/2-1 and 2-2 (to CK).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Denison, S., Wang, F., Becker, N. et al. Alterations in the common fragile site gene Parkin in ovarian and other cancers. Oncogene 22, 8370–8378 (2003). https://doi.org/10.1038/sj.onc.1207072
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207072
Keywords
This article is cited by
-
Intracellular delivery of Parkin-RING0-based fragments corrects Parkin-induced mitochondrial dysfunction through interaction with SLP-2
Journal of Translational Medicine (2024)
-
Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization
Cell Death & Disease (2023)
-
The mitophagy pathway and its implications in human diseases
Signal Transduction and Targeted Therapy (2023)
-
Nuclear respiratory factor 1 promotes the growth of liver hepatocellular carcinoma cells via E2F1 transcriptional activation
BMC Gastroenterology (2022)
-
Endoplasmic reticulum−mitochondria coupling increases during doxycycline-induced mitochondrial stress in HeLa cells
Cell Death & Disease (2021)